Thumbnail

中东和非洲胰腺癌治疗和诊断市场——按癌症类型和地理划分(2020 - 2025 年)

Looking to buy the report?

中东和非洲胰腺癌市场预计将从 2015 年的 8700 万美元适度增长,复合年增长率为 10-17%。

在全球范围内,胰腺癌是男性第 12 位最常见的癌症和女性中第 11 位最常见的癌症。吸烟成瘾和健康史被认为是增加风险的首要原因。

中东和非洲胰腺癌治疗和诊断市场-市场动态

该报告详细介绍了驱动和限制市场的几个因素,其中一些因素如下所列。

驱动程序

促进市场增长的一些因素是:

  • 与疾病相关的大量未满足需求,吸引了许多跨国公司投资该部门
  • 增加医疗保健支出
  • 胰腺癌的技术发展和药物创新
  • 世界范围内日益增长的担忧

约束

限制市场增长的一些因素是:

  • 早期诊断困难
  • 治疗选择有限,尤其是当疾病已经扩散到其他器官或身体部位时  
  • 治疗后效果不佳
  • 抗癌药物临床试验成功率低
  • 与治疗相关的高成本
  • 不良副作用
  • 药物毒性大

中东和非洲胰腺癌治疗和诊断市场根据癌症类型分为内分泌癌和外分泌癌。按治疗类型,市场分为手术、化学疗法、放射疗法和靶向疗法。通过主要测试,市场已细分为活检、超声内镜、腹腔镜和 CT 扫描 ERCP。根据地理位置,市场已细分为卡塔尔、沙特阿拉伯和南非。

市场上的一些主要参与者是:

  • 安进公司    
  • 新基公司                              
  • 克洛维斯肿瘤学公司                           
  • 礼来公司                              
  • 诺华公司                
  • 阈值制药公司                         

报告提供了什么

  • 市场定义以及市场关键驱动因素和限制因素的识别。
  • 在全球和区域范围内进行区域特定评估和竞争分析的市场分析。
  • 确定有助于改变市场情景、增加潜在机会的因素以及确定可以在全球和区域范围内影响市场的关键公司。
  • 广泛研究了竞争格局部分,包括主要公司的概况及其战略举措和市场份额。
  • 识别和分析在全球和区域范围内影响行业的宏观和微观因素。
  • 关键市场参与者的综合列表以及对其当前战略利益和关键财务信息的分析。
yle="text-align:justify">对于行业顾问、制造商和其他相关方和相关方来说,除了提供的机会外,它们还可以深入了解推动和限制市场的因素。

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Research Methodology                         

2. Executive Summary                                  

3. Market Overview                                       

                3.1 Market Drivers                          

                                3.1.1 Large Number of Unmet Needs in the Disease         

                                3.1.2 Increase in the Healthcare Expenditure   

                                3.1.3 Increasing Concern across the Globe            

                3.2 Market Restraints                    

                                3.2.1 Inadequate Results after Treatment             

                                3.2.2 Difficulties in Early Diagnosis            

                                3.2.3 High Cost Associated with the Treatment    

                                3.2.4 Low Success Rate in Clinical Trials for Cancer Drugs   

                3.3 Market Opportunities                          

                3.4 Market Threats                         

4. Porter’s Five Force Analysis                                    

                4.1 Bargaining Power of Suppliers                            

                4.2 Bargaining Power of Buyers                

                4.3 Degree of Competition                          

                4.4 Threat of Substitution                            

                4.5 Threat of New Entrants                         

5. Market Segmentation                                              

                5.1 Middle East & Africa Pancreatic Cancer Therapeutics & Diagnostic Market, by Cancer Type                               

                                5.1.1 Exocrine Cancers   

                                                5.1.1.1 Pancreatic Adenocarcinoma

                                                5.1.1.2 Acinar Cell Carcinoma

                                                5.1.1.3 Cystadenocarcinomas

                                                5.1.1.4 Others

                                5.1.2 Endocrine Cancers (PanNETs)         

                                                5.1.2.1 Functional

                                                5.1.2.2 Non-Functional

                5.2 Middle East & Africa Pancreatic Cancer Therapeutics Market                          

                                5.2.1 Surgery     

                                5.2.3 Radiation Therapy

                                5.2.3 Chemotherapy      

                                5.2.4 Chemoradiation Therapy   

                                5.2.5 Targeted Therapy 

                5.3 Middle East & Africa Pancreatic Cancer Diagnostics Market                              

                                5.3.1 ERCP          

                                5.3.2 Confirmatory Needle biopsy           

                                5.3.3 Endoscopic Ultrasound      

                                5.3.4 Laparoscopy           

                                5.3.5 CT Scan     

                                5.3.6 PET Scan   

                5.4 Middle East & Africa Pancreatic Cancer Therapeutics Market, By Region                    

                                5.4.1 Qatar         

                                5.4.2 Saudi Arabia           

                                5.4.3 South Africa            

6. Competitive Landscape                                           

                6.1 Mergers & Acquisitions                         

                6.2 Agreements, Collaborations & Partnerships                

                6.3 New Product Launches                         

                6.4 Recommendations to New Market Players                   

7. Company Profiles                                       

                7.1 Amgen, Inc.                 

                7.2 Eli Lilly and Company                              

                7.3 Celgene Corporation                              

                7.4 Clovis Oncology, Inc.                

                7.5 Novartis AG                

                7.6 Threshold Pharmaceuticals, Inc.                         

                7.7 Incyte Corp                 

                7.8 Merrimack Pharmaceuticals Inc.                         

                7.9 Roche Ltd                    

                7.10 NewLink Genetics                 

8. Appendix                                       

                8.1. Abbreviations                          

                8.2. Sources                       

                8.3. Bibliography                              

                8.4. Disclaimer                   

Looking to buy the report?

Need a report that reflects how COVID-19 has impacted this market and its growth?

Looking to customize report?

Email

Message

By submitting, you confirm that you agree to our privacy policy